American Academy of Neurology is encouraging use of some newer antiepileptics
The American Academy of Neurology is encouraging use of some newer antiepileptics...Lamictal (lamotrigine), Trileptal (oxcarbazepine), Topamax (topiramate), and Neurontin (gabapentin).
Primary providers will need to be aware of the side effects.
Experts are using some newer agents for INITIAL therapy even though they're only approved for ADJUNCTIVE therapy. The newer ones are just as effective but often better tolerated.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote